Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last C$0.22 CAD
Change Today 0.00 / 0.00%
Volume 0.0
SL On Other Exchanges
As of 1:28 PM 11/26/15 All times are local (Market data is delayed by at least 15 minutes).

supreme pharmaceuticals inc (SL) Snapshot

Previous Close
Day High
Day Low
52 Week High
12/1/14 - C$0.42
52 Week Low
08/19/15 - C$0.11
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield

Related News

No related news articles were found.

supreme pharmaceuticals inc (SL) Related Businessweek News

No Related Businessweek News Found

supreme pharmaceuticals inc (SL) Details

Supreme Pharmaceuticals Inc., a development stage company, focuses on the production and sale of medical marijuana in Canada. The company was formerly known as Supreme Resources Ltd. and changed its name to Supreme Pharmaceuticals Inc. in February 2014. Supreme Pharmaceuticals Inc. was incorporated in 1979 and is headquartered in Vancouver, Canada.

Founded in 1979

supreme pharmaceuticals inc (SL) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

supreme pharmaceuticals inc (SL) Key Developments

Supreme Pharmaceuticals Inc. Announces Executive Changes

Supreme Pharmaceuticals Inc. announced the appointment of Navdeep Dhaliwal to the company's Board of Directors. Mr. Dhaliwal's primary focus will be the development of the company’s go to market strategy in addition to corporate development and capital markets initiatives. Mr. Dhaliwal is a Chartered Accountant and currently serves as the principal of NLX Capital Corp. Mr. Dhaliwal was recently retained by a Toronto software company where he successfully expanded the company's business into South East Asia, where Mr. Dhaliwal has extensive business experience. Concurrent with Mr. Dhaliwal's appointment, the company’s Board of Directors accepted the resignation of Allan Levien, a long serving director of the company.

Supreme Pharmaceuticals Inc. Announces Executive Changes

Supreme Pharmaceuticals Inc. announced in relation to the previously announced management transition to Ontario, Tatiana Kovaleva will be resigning as the Company's Chief Financial Officer. Cailin Ghelsen, the Director of Finance for the Company's wholly owned subsidiary 8528934 Canada Ltd. ('AMMCan'), will be appointed as the interim Chief Financial Officer. Peter Herburger, the CEO of AMMCan, will be appointed as Supreme's Director of Operations.

Supreme Pharmaceuticals Inc. Completes Operational Transition to Ontario; Announces Resignation of Brayden Sutton as Executive Vice-President

Supreme Pharmaceuticals Inc. announced it has completed its operational transition from British Columbia to Ontario in order to focus resources on the Kincardine facility. The transition allows the company to reduce operating overhead and focus efforts on obtaining required regulatory approvals at the Kincardine facility. Further to the transition, Brayden Sutton will be resigning as Executive Vice-President, effective immediately, but will continue on with company as a consultant for the near term to assist in completing the company's operational transition.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SL:CN C$0.22 CAD 0.00

SL Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for SL.
View Industry Companies

Industry Analysis


Industry Average

Valuation SL Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book 1.3x
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact SUPREME PHARMACEUTICALS INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at